GT Biopharma (GTBP) had the highest return between 2007 and 2013 by a US stock, returning 57,841,400.7%.
| ASSET | YEARS | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 2007-2013 | 57,841,400.73% |
Northern Oil & Gas (NOG) | 2007-2013 | 4,861,180.77% |
Future Fintech (FTFT) | 2007-2013 | 3,397,958.25% |
Sequans Communications (SQNS) | 2007-2013 | 2,409,538.55% |
QXO (QXO) | 2007-2013 | 2,352,000% |
Nutex Health (NUTX) | 2007-2013 | 749,900.2% |
Natwest (NWG) | 2007-2013 | 712,040% |
Sandstorm Gold Ltd N (SAND) | 2007-2013 | 684,366.67% |
Ageagle Aerial Systems (UAVS) | 2007-2013 | 659,899.57% |
Castellum (CTM) | 2007-2013 | 469,465.22% |
Ring Energy (REI) | 2007-2013 | 406,566.67% |
Ferguson (FERG) | 2007-2013 | 384,838.1% |
Metalla Royalty & Streaming (MTA) | 2007-2013 | 353,033.33% |
PharmaCyte Biotech (PMCB) | 2007-2013 | 90,242.86% |
BioLineRx (BLRX) | 2007-2013 | 27,132.64% |
Pioneer Power Solutions (PPSI) | 2007-2013 | 20,520.38% |
Weatherford International (WFRD) | 2007-2013 | 10,400% |
Kandi Technologies (KNDI) | 2007-2013 | 7,760% |
Actinium Pharmaceuticals (ATNM) | 2007-2013 | 5,254.54% |
Par Pacific (PARR) | 2007-2013 | 3,616.67% |
Altisource Portfolio Solutions (ASPS) | 2007-2013 | 2,945.05% |
Nova Lifestyle I (NVFY) | 2007-2013 | 2,906.67% |
Champions Oncology (CSBR) | 2007-2013 | 2,900% |
MiMedx (MDXG) | 2007-2013 | 2,726.65% |
Booking (BKNG) | 2007-2013 | 2,543.02% |
